{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:48:07Z","timestamp":1782712087801,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background &amp;amp; aims<\/jats:title>\n                    <jats:p>Biliary atresia (BA) is the leading cause of cholestatic liver disease and cirrhosis in infancy. Currently, there is a lack of efficient biomarkers for early diagnosis and prognostic evaluation of this disease, which urgently needs to be addressed. This study aimed to screen and validate key biomarkers closely associated with BA liver fibrosis progression and prognosis through bioinformatics analysis combined with clinical sample verification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>First, the public transcriptomic dataset GSE122340 was thoroughly analyzed to screen differentially expressed genes, followed by construction of a protein\u2013protein interaction (PPI) network. Epithelial cell transforming sequence 2 (ECT2) was ultimately identified as the core hub gene. Subsequently, clinical samples were collected, including 20 cases in the BA group (stratified by liver fibrosis severity) and 10 cases in the choledochal cyst control group. The expression level of ECT2 was clinically verified using immunohistochemistry, real-time quantitative polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristic (ROC) curve analysis was performed to validate the predictive efficacy of serum ECT2 level for BA diagnosis, fibrosis stratification, and postoperative native liver survival. Kaplan\u2013Meier (KM) curve analysis was used to verify the relationship between serum ECT2 level and postoperative native liver survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ECT2 was significantly highly expressed in liver tissue (both mRNA and protein levels) and serum of BA patients, and its expression intensity was positively correlated with the severity of liver fibrosis. ROC curve analysis showed that serum ECT2 exhibited favorable efficacy in BA diagnosis, liver fibrosis stratification, and prediction of 2-year postoperative native liver survival, with area under the curve (AUC) values of 0.906, 0.807, and 0.844.Compared with MMP7, it demonstrates comparable predictive performance in the diagnosis of BA (AUC\u2009=\u20090.924) and the stratification of liver fibrosis (AUC\u2009=\u20090.829), and outperforms MMP7 in predicting autologous liver survival (AUC\u2009=\u20090.767). Its overall predictive performance is superior to that of traditional liver function markers (GGT, TBIL, TBA). Kaplan\u2013Meier survival analysis further confirmed that BA patients with high serum ECT2 expression had significantly reduced native liver survival rates postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study systematically demonstrates that ECT2 is characteristically highly expressed in BA and its association with disease fibrosis severity and poor prognosis. Preliminary findings suggest that serum ECT2 as a promising non-invasive biomarker, providing new technical approaches and theoretical basis for clinical diagnosis, disease assessment, and prognostic judgment of BA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1879864","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:40:54Z","timestamp":1782711654000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia"],"prefix":"10.3389","volume":"14","author":[{"given":"Yuqiang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of General Surgery, Urumqi Children's Hospital","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Urumqi Children's Hospital","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Yang","sequence":"additional","affiliation":[{"name":"General Surgery Department, Tianjin Children's Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[{"name":"General Surgery Department, Tianjin Children's Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alimujiang","family":"Abudureyimu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Urumqi Children's Hospital","place":["Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Zhan","sequence":"additional","affiliation":[{"name":"General Surgery Department, Tianjin Children's Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","article-title":"Biliary atresia","volume":"10","author":"Tam","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"760182","DOI":"10.3389\/fgene.2021.760182","article-title":"Identifying biomarkers to predict the prognosis of biliary atresia by weighted gene co-expression network analysis","volume":"12","author":"Kong","year":"2021","journal-title":"Front Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"151473","DOI":"10.1016\/j.sempedsurg.2025.151473","article-title":"Predicting and managing liver fibrosis in biliary atresia","volume":"33","author":"Nyholm","year":"2024","journal-title":"Semin Pediatr Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/children8090820","article-title":"Extended adhesion-sparing liver eversion during Kasai portoenterostomy for infants with biliary atresia","volume":"8","author":"Parolini","year":"2021","journal-title":"Children (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15796","DOI":"10.1038\/s41598-024-66893-2","article-title":"Biliary atresia and cholestasis plasma non-targeted metabolomics unravels perturbed metabolic pathways and unveils a diagnostic model for biliary atresia","volume":"14","author":"Du","year":"2024","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.7499\/j.issn.1008-8830.2205180.","article-title":"New advances in the diagnosis and treatment of biliary atresia","volume":"24","author":"Wang","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.1002\/ctm2.1070","article-title":"Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia","volume":"12","author":"Ye","year":"2022","journal-title":"Clin Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41417-022-00525-7","article-title":"ECT2 promotes malignant phenotypes through the activation of the AKT\/mTOR pathway and cisplatin resistance in cervical cancer","volume":"30","author":"Liu","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1053\/j.gastro.2019.06.017","article-title":"Gene expression signatures associated with survival times of pediatric patients with biliary atresia identify potential therapeutic agents","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","article-title":"Limma: linear models for microarray data","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"Smyth","year":"2005"},{"key":"B11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","article-title":"GOplot: an R package for visually combining expression data with functional analysis","volume":"31","author":"Walter","year":"2015","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12887-023-04413-3","article-title":"Development and post-Kasai procedure prognostic relevance of histological features for biliary atresia","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1726141","DOI":"10.3389\/fmed.2025.1726141","article-title":"Liver fibrosis in biliary atresia: identification of the key gene EDIL3 via integrated bioinformatics","volume":"12","author":"Kong","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/children9050697","article-title":"Identification of hub genes and immune infiltration in pediatric biliary atresia by comprehensive bioinformatics analysis","volume":"9","author":"Li","year":"2022","journal-title":"Children (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1611564","DOI":"10.3389\/fped.2025.1611564","article-title":"MFAP4 as a novel biomarker for predicting liver fibrosis and prognosis in infants with biliary atresia through the integration of bioinformatics with clinical data analysis","volume":"13","author":"Yang","year":"2025","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00383-022-05322-9","article-title":"A novel model based on immune-related genes for differentiating biliary atresia from other cholestatic diseases","volume":"39","author":"Li","year":"2022","journal-title":"Pediatr Surg Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"108805","DOI":"10.1016\/j.celrep.2021.108805","article-title":"The BRCT domains of ECT2 have distinct functions during cytokinesis","volume":"34","author":"Schneid","year":"2021","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"C698","DOI":"10.1152\/ajpcell.00486.2023","article-title":"Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights","volume":"326","author":"Marakovits","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s12072-022-10322-x","article-title":"Dynamic analysis of serum MMP-7 and its relationship with disease progression in biliary atresia: a multicenter prospective study","volume":"16","author":"Chi","year":"2022","journal-title":"Hepatol Int"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1879864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:40:57Z","timestamp":1782711657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1879864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":21,"alternative-id":["10.3389\/fped.2026.1879864"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1879864","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1879864"}}